<DOC>
	<DOC>NCT01333150</DOC>
	<brief_summary>The project's primary purpose is to test the hypothesis that oral administration of a low single dose of Î²-antagonist propranolol (40 mg) reduces pain sensitivity in patients with masticatory muscle pain.</brief_summary>
	<brief_title>Effect of Propranolol on the Autonomic Nervous System and Muscle Pain</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Temporomandibular Joint Disorders</mesh_term>
	<mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Meet Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) for myofascial TMD diagnosis corresponding to group 1a or 1b Characteristic Pain Intensity (CPI) more than or equal to 20 (Axe II, RDC/TMD questionnaire) Women of childbearing potential must use adequate contraception Signed consent statement Other acute pain cause such as acute toothache or a pain condition the investigator estimates to be contraindicated for participation in the experiment Recognized existing malignancy or within last 5 years Known HIV Abuse of drugs including alcohol Recognized Raynaud's syndrome Former sympathectomy Known cardiovascular disease including abnormal EKG and blood pressure (ECG12 is recorded before the first trial session and assessed by the physician) Recognized lung insufficience, including bronchial asthma Known severe hepatic or renal dysfunction Known diabetes mellitus Known severe depression Pregnancy (tests performed in both sessions 1 and 2 before the start of a session) Fertility Treatment Lactation Postmenopausal Previous adverse reaction when taking betablocker, including hypersensitivity to propranolol or to any of the excipients Patients who can not read and understand the written information Patients who can not follow the protocol Patients who do not agree to comply with the requirements for participation in both studies regarding food intake, physical activity, etc.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Temporomandibular disorders</keyword>
	<keyword>Orofacial pain</keyword>
</DOC>